STRATEGIES & TECHNOLOGIES DRIVING DRUG DISCOVERY TO MARKET

info@drugdiscoverycongress.org

29th October
2023
J.N.TATA Auditorium, Indian Institute of Science, Bengaluru.

Investment Opportunities

  • India is expected to be the third largest global market for active pharmaceutical ingredients by 2016, with a 7.2% increase in market share.
  • Indian pharma companies registered 49% of overall DMF filed in the US in 2012.
  • The Contract Research and Manufacturing Services industry – estimated at USD 8 Billion in 2015, up from USD 3.8 Billion in 2012. The market has more than 1000 players.
  • The formulations industry – India is the largest exporter of formulations with 14% market share and ranks 12th in the world in terms of export value. Double-digit growth is expected over the next five years.

Foreign Investors

  • Teva Pharmaceuticals (Israel)
  • Nipro Corporation (Japan)
  • Procter & Gamble (USA)
  • Pfizer (USA)
  • Glaxo Smith Kline (UK)
  • Johnson & Johnson (USA)
  • Otsuka Pharmaceutical (Japan)
  • AstraZeneca (Sweden-UK)

Agencies

  • Department Of Pharmaceuticals, Ministry Of Chemicals & Pharmaceuticals
  • Indian Drug Manufacturers Association
  • Bulk Drug Manufacturers Association
  • Pharmexcil
  • Federation Of Pharma Entrepreneurs
  • Confederation Of Indian Pharmaceutical Industry
  • Indian Pharmaceutical Alliance

Enquiry


Quick Links


Call for Abstracts
Online Registration
Oral Presentation
Poster Presentation

Organizers

Journal Publishing Partner.

Branding Partners

Supporters

© WORLD CONGRESS ON DRUG DISCOVERY & DEVELOPMENT ®
by BioGenesis Conferences.

Designed & Developed by mokshamedia